Accessibility Menu
OpGen logo

OpGen(OTC) OPGN

Current Price$7.78
Market Cap$112.57MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2015)-100%
5 Year-98%
1 Year+19,696%
1 Month+285%
OpGen last closing stock price
MetricPriceDate
Last closeUSD 7.782026-07-23
OpGen stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-61.1%USD 20.002026-07-16
1 month+285.15%USD 2.022026-06-23
3 month+1,555,900%USD 0.002026-04-24
Year to date-51.07%USD 15.902025-12-31
1 year+19,696.44%USD 0.042025-07-23
3 year+32.61%USD 5.872023-07-24
5 year-98.26%USD 446.002021-07-23
Since inception-100%USD 485,000.002015-05-05

OpGen Financials at a Glance

Market Cap

$112.57MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$30.20M

Net Income (TTM)

$23.32M

EPS (TTM)

$2.29

P/E Ratio

3.97

Dividend

$0.00

Beta (Volatility)

-1137.00 (Low)

Price

$7.78

Volume

137

Open

$7.78

Previous Close

$7.78

Daily Range

$7.78 - $7.78

52-Week Range

$7.78 - $34.00

Estimated Earnings Date

Apr 2, 2026

OPGN News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About OpGen

OpGen helps companies list on stock exchanges and manage their ownership records. Its services support international businesses seeking public listings and digital investment banking. The company’s tools aim to simplify complex financial processes for clients worldwide.

Products and Services

  • Listing Sponsorship: Consultancy for international companies seeking to list shares on public exchanges (0% of Q1 2025 revenue).
  • Digital Investment Banking: Planned services for online banking, securities trading, and advisory (no revenue yet).
  • Fintech Cap Table Management: Tools to track company ownership and share distribution (no revenue yet).
  • Legacy Diagnostics: Former products for infectious disease testing, now discontinued (approximately 84% of Q1 2024 revenue).

Growth and Expansion

  • Formed CapForce International Holdings in late 2023 to enter financial services and technology.
  • Exited legacy diagnostics business and deconsolidated Curetis and Ares Genetics in 2023.
  • Partnered with AEI Capital for equity investment and industry expertise in 2024.
  • Launched joint venture with European Credit Investment Bank in April 2025 for global digital banking.

What Makes OpGen Stand Out

OpGen shifted from medical diagnostics to financial technology, focusing on virtual operations and digital services. Its partnership with AEI Capital and joint venture with ECIB support global reach and new business lines. The company’s ability to pivot quickly highlights operational flexibility in changing markets.

Five Things You Need to Know

  • Revenue was $4 million in QQ2 2025, up 14,185.7% from QQ2 2024.
  • Operating income reached $3 million in QQ2 2025, up 320% year-over-year.
  • Net income was $4 million in QQ2 2025, up 322.7% from QQ2 2024.
  • Cash used in operations improved 37.9% in QQ2 2025 versus QQ2 2024.

Bottom Line

OpGen has transformed from a diagnostics company to a financial technology provider. Its recent pivots and partnerships reflect a focus on adaptability and new market opportunities.

AI Generated • Apr 16, 2026

Industry

Biotechnology

Sector

Health Care

Employees

6

CEO

Christian-Laurent Bonte

Website

www.opgen.com

Headquarters

Rockville, MD 20850, US

OPGN Financials

Key Financial Metrics (TTM)

Gross Margin

89.99%

Operating Margin

78.63%

Net Income Margin

77.21%

Return on Equity

111.12%

Return on Capital

71.29%

Return on Assets

62.26%

Earnings Yield

25.19%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$112.57MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

12.38M

Volume

137

Avg. Volume

346.597

Financials (TTM)

Gross Profit

$27.23M

Operating Income

$24.55M

EBITDA

$3.10M

Operating Cash Flow

-$1.35M

Capital Expenditure

$0.00

Free Cash Flow

-$1.35M

Cash & ST Invst.

$78.59K

Total Debt

$1.80M

OpGen Performance Analysis

OpGen annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 2,607,293-39.5%
20232023-12-31USD 3,418,32031.1%
20242024-12-31USD 5,196,14952.0%
20252025-12-31USD 30,200,000481.2%
OpGen sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-30N/A
Q32025-09-30-100.0%
Q42025-12-31N/A
Q12026-03-31-100.0%
OpGen annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -152.70-33.3%
20232023-12-31USD -41.47-72.8%
20242024-12-31USD 2.30N/A
20252025-12-31USD 2.320.9%
OpGen sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-30939.5%
Q32025-09-30-117.8%
Q42025-12-313543.7%
Q12026-03-31-102.9%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

+100.0%

Gross Margin

0.00%

N/A

Market Cap

$112.57MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$1.32M

N/A

Employees

85

N/A

Net Income

-$710.57K

-74.1%

EBITDA

$50.37K

+114.0%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$78.59K

-92.9%

Total Debt

$1.80M

-9.1%

Accounts Receivable

$253.69K

+644.1%

Inventory

$0.00

N/A

Long Term Debt

$1.59M

-11.7%

Short Term Debt

$210.17K

+16.4%

Return on Assets

62.26%

N/A

Return on Invested Capital

72.29%

N/A

Free Cash Flow

-$363.83K

-83.9%

Operating Cash Flow

-$363.83K

-83.9%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
INTIInhibitor Therapeutics, Inc.
$0.09+14.47%
UNVCUnivec, Inc.
$0.00+21.88%
LIANYLianBio
$0.06-20.00%
NSVGFNass Valley Gateway Ltd.
$0.01+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.76-0.29%
NOKNokia
$9.73-0.05%
AALAmerican Airlines Group
$13.56-0.08%
SMCISuper Micro Computer
$31.20+0.02%

Questions About OPGN

What is the current price of OpGen?

OpGen is trading at $7.78 per share.

What is the 52-week range for OpGen?

Over the past 52 weeks, OpGen has traded between $7.78 and $34.00.

How much debt does OpGen have?

As of the most recent reporting period, OpGen reported total debt of $1.80M.

How much cash does OpGen have on hand?

OpGen reported $78.59K in cash and cash equivalents in its most recent financial results.

What is OpGen’s dividend yield?

OpGen does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services